INTERNATIONAL STEM CELL CORPORATION (ISCO)

Every figure this model derived for ISCO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 36,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,089,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 3,920,000 AssetsCurrent 2026-06-30
current liabilities 4,984,000 LiabilitiesCurrent 2026-06-30
equity -4,228,000 StockholdersEquity 2026-06-30
interest expense 141,000 InterestExpense 2026-06-30
ocf 369,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 9,514,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 250,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ISCO on one particular measure came for.

RatioValue
cash operating margin-0.23
current ratio0.79
current ratio reported0.79
dilution pct0.0
fcf margin3.5
growth cv1.58
interest cover-3.15
operating margin-4.67
owner earnings margin0.87
revenue growth3.4
revenue growth per share3.4
rule of 40-1.27
sbc pct revenue2.63

What to be careful about

What this model itself distrusts about ISCO's figures. Written by the derivation as it ran, not added afterwards.